Dianna S. Howard

Atrium Health Wake Forest Baptist — United States

Medicine · Health Sciences

23h-index3.6kcitations116works12.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(51), Hematopoietic Stem Cell Transplantation(21), Histone Deacetylase Inhibitors Research(16), Acute Lymphoblastic Leukemia research(15), Childhood Cancer Survivors' Quality of Life(12)

Publications116 total

Treatment patterns and outcomes of primary central nervous system lymphoma treated with high-dose methotrexate with or without autologous stem cell transplantation or whole brain radiation in the rea-world setting
Blood·2025
Physician Advocacy for Hematopoietic Cell Transplantation and Cell Therapy: Overcoming Challenges to Reduce Disparities and Improve Outcomes for Patients
Transplantation and Cellular Therapy·2025
Pilot study of an inpatient physical activity intervention for older adults treated intensively for acute myeloid leukemia
Blood Advances·2025· 2 citedOpen Access
Retrospective review of relapse after allogeneic stem cell transplant for myeloid malignancy.
Journal of Clinical Oncology·2025
Barriers to Allogeneic Stem Cell Transplant in Patients with Malignant and Non-Malignant Hematologic Conditions
Transplantation and Cellular Therapy·2025
Feasibility of implementing a culturally and linguistically adapted telephone-based cognitive-behavioral therapy (CBT) intervention for depression and anxiety with Hispanic and Latino cancer survivors
Journal of Psychosocial Oncology·2024· 1 citedOpen Access
Optimization of a digital health intervention to enhance well-being among adolescent and young adult cancer survivors: Design and methods of the EMPOWER full factorial trial
Contemporary Clinical Trials·2024· 3 citedOpen Access
High-dimensional Immune Profiles and Machine Learning May Predict Acute Myeloid Leukemia Relapse Early following Transplant
The Journal of Immunology·2024· 2 cited
Real-World Analysis of Barriers to Timely Administration of Chimeric Antigen Receptor T Cell (CAR T) Therapy in Diffuse Large B-cell Lymphoma
Transplantation and Cellular Therapy·2024· 12 citedOpen Access
In Pursuit of Optimal Outcomes: A Framework for Quality Standards in Immune Effector Cell Therapy
Transplantation and Cellular Therapy·2024· 4 cited
Asking the “Right” Questions about Financial Hardship: Using Cognitive Interviews with Adolescents and Young Adults with Cancer and Their Caregivers to Inform Measure Development
Journal of Adolescent and Young Adult Oncology·2024· 3 citedOpen Access
SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational Study
Clinical Infectious Diseases·2024· 19 citedOpen Access
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>
Journal of Clinical Oncology·2024· 156 citedOpen Access
Riding the Wave: Risk Factors for Acute Kidney Injury in Patients Receiving Ptcy with Hyperhydration
Transplantation and Cellular Therapy·2024· 1 cited
Donor Search and Selection Strategy to Facilitate Comparable Transplant Rates across Donor Search Prognosis Groups: A Report from the BMT CTN 1702 Trial
Transplantation and Cellular Therapy·2024· 2 cited
SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101)
2024· 2 citedOpen Access
Optimization of a Digital Health Intervention to Enhance Well-Being Among Adolescent and Young Adult Cancer Survivors: Design and Methods of the Empower Full Factorial Trial
SSRN Electronic Journal·2024Open Access
Cultural and linguistic adaptation of a telephone-based cognitive-behavioral therapy (CBT) intervention to treat depression and anxiety in Hispanic cancer survivors
Journal of Psychosocial Oncology·2023· 6 citedOpen Access
The Transplantation Ecosystem: A New Concept to Improve Access and Outcomes for Older Allogeneic Hematopoietic Cell Transplantation Patients
Transplantation and Cellular Therapy·2023· 12 cited
Data from A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Bayard L. Powell(10), Timothy S. Pardee(9), Leslie R. Ellis(9), Susan Lyerly(8), Donna Reece(7), Scott Isom(7), Megan Manuel(7), Sarah Dralle(7), Craig T. Jordan(6), Gordon L. Phillips(6), Mónica L. Guzmán(5), Asmita Mishra(5), Andrew Artz(5), Suzanne C. Danhauer(5), Vijaya Raj Bhatt(4), Kristin M. Pladna(4), Dmitriy Berenzon(4), Rupali Bhave(4), John M. Salsman(4), Chandylen L. Nightingale(4)